Adar Poonawalla's Serum Institute Gets Notice On Pausing Vaccine Trial | Read

PUBLISHED ON: September 9, 2020 | Duration: 1 min, 45 sec

  
loading..
The Serum Institute of India, which is manufacturing the Oxford University's Covishield vaccine and will hold the phase 3 clinical trials in India from next week, has been issued a showcause notice by the country's drug controller DGCI. Trials for the vaccine were stopped in four nations as a precautionary measure after one of the recipients in the UK showed some adverse symptoms, which are yet to be linked to the vaccine.
ALSO WATCH
"Others From Bangladesh?": Uddhav Thackeray On BJP's Bihar Free Vaccine Promise

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com